Activation of CISD2 as a protective strategy against doxorubicin-induced cardiotoxicity
Our results highlight the potential utility of Cisd2 and its activator hesperetin in chemotherapy involving doxorubicin.
Authors
- Chi‐Hsiao Yeh
- Chien-Yi Tung (ORCID: https://orcid.org/0000-0002-1467-2575)
- Chian‐Feng Chen
- Zhao‐Qing Shen (ORCID: https://orcid.org/0000-0001-9126-0219)
- Wen‐Tai Chiu (ORCID: https://orcid.org/0000-0003-0310-0675)
- Tsai‐Yu Tzeng (ORCID: https://orcid.org/0000-0001-7334-6270)
- Ting‐Fen Tsai (ORCID: https://orcid.org/0000-0003-3239-4430)
- Yi-Ju Chou
- Chung-Kuang Lu
- Patrick C.H. Hsieh (ORCID: https://orcid.org/0000-0002-8910-3596)
- Chi-Jen Lo (ORCID: https://orcid.org/0000-0003-4439-8033)
- Jinn‐Moon Yang (ORCID: https://orcid.org/0000-0002-3205-4391)
- Cheng-Heng Kao
- Shu-Ling Fu
- Mei‐Ling Cheng
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Health Research Institutes (TW)
- Chang Gung University (TW)
- National Research Institute of Chinese Medicine (TW)
- Institute of Biomedical Sciences, Academia Sinica (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Redox Biology
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1016/j.redox.2025.103840
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39